Literature DB >> 2563651

Inhibition of purified human postheparin lipoprotein lipase by beta-adrenergic blockers in vitro.

S Kihara1, M Kubo, N Ikeda, S Yokoyama, Y Matsuzawa, S Tarui, A Yamamoto, K Y Hostetler.   

Abstract

We examined the effects of five beta-adrenergic blockers on the hydrolysis of phosphatidylcholine-stabilized triolein particles by purified human postheparin lipoprotein lipase (PHLpL) in order to evaluate the possible role of direct inhibition as a mechanism of drug-induced hypertriglyceridemia. The relative inhibitory potencies were observed in the following order: propranolol much greater than pindolol greater than metoprolol greater than atenolol greater than nadolol. There was a positive correlation between the octanol/water partition coefficients of these agents and their inhibition of lipoprotein lipase, suggesting that hydrophobicity may be one of the major determinants for PHLpL inhibition. The amount of the beta-adrenergic blockers required to produce 50% inhibition of human PHLpL was much greater than that required to inhibit purified bovine lipoprotein lipase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563651     DOI: 10.1016/0006-2952(89)90379-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  1 in total

1.  Lipid abnormalities in rats given small doses of lead.

Authors:  A Skoczyńska; R Smolik; M Jeleń
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.